ACB

Research · Apr 23, 2026

Trump's Reported Marijuana Reclassification: Tilray Rally Just Beginning?

Tilray leads cannabis surge on Trump reclassification reports confirming Schedule III path. Upside of 20-30% TLRY, 15-25% CGC, 10-20% ACB over 3 days as banking and tax relief unlock. Breaks on report retraction or congressional punt by July.